Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

SARONG is a multi-centre, open-label, two-arm, parallel design, superiority Randomised Controlled Trial funded by NIHR-HTA and sponsored by the University of Oxford. The aim of the trial is to assess whether intensive surveillance after completing curatively intended treatment improves survival and health-related quality of life in patients with oesophageal or gastric cancer. We are pleased to say that SARONG is now open to recruitment, and 10 participants have been recruited in Oxford and one participant in Southampton so far (19Jul2023).

For more information or updates follow us on Twitter @SARONG_Trial and visit our website: